Fast Company3 min read
A personalized cancer vaccine could be available as soon as 2027. Here’s what we know
A breakthrough treatment for the deadliest form of skin cancer can cut a patient’s risk of recurrence or death nearly in half. The new scientific revelation is powered by an mRNA-based vaccine crafted with the technology behind both Pfizer and Moderna’s landmark COVID-19 shots.
By Taylor HatmakerFast Company AI

Read the full story
Originally published by Fast Company AI on Oct 23, 2026.
Comments
Sign in to join the discussion.